Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-035070

Options or other derivatives

  • Director acquired 7,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Maykin Director 2018-05-31 Grant or award · Stock option (right to buy) +5,700 5,700 D: show line 1 in the form
Ho Maykin Director 2018-05-31 Grant or award · Restricted stock units +1,400 1,400 D: show line 2 in the form
Loading xslF345X03/doc4.xml…